Research Directory

Debate heats up over access to clinical trial data

Read more

The EU Clinical Trials Directive - Debate over new legislation reaches final stage

Read more

The EU Transparency Directive: Further debate on market access

Read more

The changing model for rare disease R&D

Read more

Diabetes reimbursement at risk in Germany

Read more

Adaptive licensing: A new approach for drug approvals

Read more

EU Transparency Directive: changes afoot on pricing and reimbursement

Read more

German drug policy puts pressure on prices in Europe

Read more

EU pharmacovigilance law comes into force

Read more

The outlook for new clinical trials legislation in Europe

Read more